Bristol-Myers, Novartis bid for DuPont's drug business

Article Abstract:

Novartis AG and Bristol-Myers Squibb Co. have made offers to acquire DuPont Co.'s pharmaceuticals operations. The sale of the operations is expected raise over $6 billion (7.08 billion euros).

Foreign operations, E.I. du Pont de Nemours and Co., Bristol-Myers Squibb Co., BMY

---

Merck acquires drug researcher in equity deal

Article Abstract:

Merck and Co. said that it has acquired Rosetta Inpharmatics Inc. of Kirkland, Washington. The deal is valued at approximately $620 million (707.3 million euros).

Prepackaged software, Software Publishers, Engineering, Mfg Software Pkgs (Micro), Computer software industry, Software industry, Scientific software, Engineering software, Merck & Company Inc., Rosetta Inpharmatics Inc.

---

Novartis explores options on Aventis; giant Swiss drug maker weighs white knight role aimed at thwarting Sanofi

Article Abstract:

Swiss pharmaceutical giant Novartis AG is considering acquiring Aventis SA. This potential friendly merger would thwart the 46 billion Euro hostile takeover of Aventis launched by Sanofi-Synthelabo, SA in late Jan 2004.

France, Company acquisition/merger, Acquisitions and mergers, Aventis S.A., AVE, Hostile takeovers, Sanofi-Sythelabo

Similar abstracts:

• Abstracts: Novartis talks to Aventis about white-knight offer: preliminary discussions come as French drug maker tries to fight off Sanofi bid
• Abstracts: DaimlerChrysler's Neon gets all gussied up; makeover marks shift in marketing to play up compacts. Chop Shop: Cuts at GM Portend Bigger Overhaul
• Abstracts: Webvan Group closes operations, while NCR issues profit warning. Teligent announces loss, job cuts
• Abstracts: China challenges mobile giants; home-grown standard could compete with U.S., European technologies. Which? May not be making waves about health and mobile phones
• Abstracts: Michelin makes tracks in Asia; tire maker is on lookout for alliance. Michelin workers agree to accept offer for 35 hours

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.